Abstract

Bioactivity-guided fractionation was used to isolate two compounds, tomentosenol A (1) and torellianone A (2), from a cerumen extract from Tetragonula carbonaria. The anti-fibrotic activity of these compounds was examined using human cultured neonatal foreskin fibroblasts (NFF) and immortalised keratinocytes (HaCaTs). Tomentosenol A (1), inhibited NFF and HaCaT cell proliferation and prevented NFF and HaCaT scratch wound repopulation at 12.5-25 mu M concentrations. These inhibitory effects were associated with reduced cell viability, determined by tetrazolium dye (MTT) and sulforhodamine B (SRB) assays. Compound 1 further inhibited transforming growth factor-beta(1) (TGF-beta(1))-stimulated, NFF-myofibroblast differentiation and soluble collagen production; and was an effective scavenger of the model oxidant, 2,2-diphenyl-1-picrylhydrazyl (DPPHGreek ano teleia), with an EC50 value of 44.7 +/- 3.1 mu M. These findings reveal significant anti-fibrotic potential for cerumen-derived tomentosenol A (1).

Authors	Hamilton, Karina D.; Czajkowski, Daniel; Kong, Nicolas J.; Tran, Trong D.; Gustafson, Kirk R.; Pauly, Gary; Boyle, Glen M.; Simmons, Jacinta L.; Steadman, Robert; Moseley, Ryan; Brooks, Peter R.; Ogbourne, Steven M.; Russell, Fraser D.
Journal	ANTIOXIDANTS
Pages
Volume	11
Date	1/01/2022
Grant ID
Funding Body
URL	http://www.ncbi.nlm.nih.gov/pubmed/?term=10.3390/antiox11081604